EGFR and colorectal carcinoma: In light of this, our findings that RAF, MEK, PI3K and EGFR inhibitors did not cooperate with MLKL in killing CRC cells (Fig. 1E) are not surprising since these agents promote, rather than inhibit, autophagy in various cancer cell types, including CRC cells [48–50].